Roberta Modica

1.8k total citations
74 papers, 934 citations indexed

About

Roberta Modica is a scholar working on Epidemiology, Oncology and Neurology. According to data from OpenAlex, Roberta Modica has authored 74 papers receiving a total of 934 indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Epidemiology, 47 papers in Oncology and 35 papers in Neurology. Recurrent topics in Roberta Modica's work include Neuroendocrine Tumor Research Advances (52 papers), Lung Cancer Research Studies (36 papers) and Neuroblastoma Research and Treatments (32 papers). Roberta Modica is often cited by papers focused on Neuroendocrine Tumor Research Advances (52 papers), Lung Cancer Research Studies (36 papers) and Neuroblastoma Research and Treatments (32 papers). Roberta Modica collaborates with scholars based in Italy, Germany and United Kingdom. Roberta Modica's co-authors include Antongiulio Faggiano, Annamaria Colao, Annamaria Colao, Alessia Liccardi, Barbara Altieri, Giovanna Muscogiuri, Luigi Barrea, Silvia Savastano, Valentina Guarnotta and Elisa Giannetta and has published in prestigious journals such as Blood, The Journal of Clinical Endocrinology & Metabolism and International Journal of Molecular Sciences.

In The Last Decade

Roberta Modica

66 papers receiving 924 citations

Peers

Roberta Modica
Roberta Modica
Citations per year, relative to Roberta Modica Roberta Modica (= 1×) peers Aura D. Herrera‐Martínez

Countries citing papers authored by Roberta Modica

Since Specialization
Citations

This map shows the geographic impact of Roberta Modica's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Modica with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Modica more than expected).

Fields of papers citing papers by Roberta Modica

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Modica. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Modica. The network helps show where Roberta Modica may publish in the future.

Co-authorship network of co-authors of Roberta Modica

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta Modica. A scholar is included among the top collaborators of Roberta Modica based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta Modica. Roberta Modica is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Modica, Roberta, et al.. (2025). Tumor Growth Rate in Neuroendocrine Neoplasms: An Additional Tool for Treatment Strategies?. Medicina. 61(10). 1852–1852.
2.
Modica, Roberta, et al.. (2024). Role of Bone Metastases in Lung Neuroendocrine Neoplasms: Clinical Presentation, Treatment and Impact on Prognosis. International Journal of Molecular Sciences. 25(16). 8957–8957. 2 indexed citations
3.
Modica, Roberta, Anna La Salvia, Alessia Liccardi, et al.. (2024). Dyslipidemia, lipid-lowering agents and neuroendocrine neoplasms: new horizons. Endocrine. 85(2). 520–531. 7 indexed citations
4.
Modica, Roberta, et al.. (2024). Recent advances and future challenges in the diagnosis of neuroendocrine neoplasms. Minerva Endocrinology. 49(2). 158–174. 10 indexed citations
5.
Modica, Roberta, et al.. (2023). Parathyroid diseases and metabolic syndrome. Journal of Endocrinological Investigation. 46(6). 1065–1077. 5 indexed citations
6.
Altieri, Barbara, Anna La Salvia, Roberta Modica, et al.. (2023). Recurrence-Free Survival in Early and Locally Advanced Large Cell Neuroendocrine Carcinoma of the Lung after Complete Tumor Resection. Journal of Personalized Medicine. 13(2). 330–330. 4 indexed citations
7.
Modica, Roberta, Marialaura Del Basso De, Pasquale Pisapia, et al.. (2022). Interventional cytopathologist can successfully combine ultrasonographical and microscopic skills to narrow the differential diagnosis in fine needle aspiration of neck paraganglioma. Cytopathology. 34(1). 87–90. 2 indexed citations
8.
Feola, Tiziana, Giulia Puliani, Franz Sesti, et al.. (2022). Risk factors for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a three-centric case–control study. Journal of Endocrinological Investigation. 45(4). 849–857. 33 indexed citations
9.
Giannetta, Elisa, Franz Sesti, Roberta Modica, et al.. (2022). What Lies behind Paraneoplastic Hypercalcemia Secondary to Well-Differentiated Neuroendocrine Neoplasms? A Systematic Review of the Literature. Journal of Personalized Medicine. 12(10). 1553–1553. 6 indexed citations
10.
Fanciulli, Giuseppe, Roberta Modica, Anna La Salvia, et al.. (2022). Immunotherapy of Neuroendocrine Neoplasms: Any Role for the Chimeric Antigen Receptor T Cells?. Cancers. 14(16). 3991–3991. 9 indexed citations
11.
Altieri, Barbara, Luigi Barrea, Roberta Modica, et al.. (2021). Vitamin D deficiency and tumor aggressiveness in gastroenteropancreatic neuroendocrine tumors. Endocrine. 75(2). 623–634. 10 indexed citations
12.
Barrea, Luigi, Giovanna Muscogiuri, Gabriella Pugliese, et al.. (2021). Chronotype: what role in the context of gastroenteropancreatic neuroendocrine tumors?. Journal of Translational Medicine. 19(1). 324–324. 13 indexed citations
13.
Lania, Andrea, Francesco Ferraù, Manila Rubino, et al.. (2021). Neoadjuvant Therapy for Neuroendocrine Neoplasms: Recent Progresses and Future Approaches. Frontiers in Endocrinology. 12. 651438–651438. 16 indexed citations
14.
Puliani, Giulia, Franz Sesti, Tiziana Feola, et al.. (2020). Natural History and Management of Familial Paraganglioma Syndrome Type 1: Long-Term Data from a Large Family. Journal of Clinical Medicine. 9(2). 588–588. 7 indexed citations
15.
Verde, Francesco, Valeria Romeo, Teresa Perillo, et al.. (2020). Pancreatic Neuroendocrine Tumors in Patients with Multiple Endocrine Neoplasia Type 1: Diagnostic Value of Different MRI Sequences. Neuroendocrinology. 111(7). 696–704. 4 indexed citations
16.
Sciammarella, Concetta, Amalia Luce, Ferdinando Riccardi, et al.. (2020). Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to Everolimus. Frontiers in Oncology. 10. 1047–1047. 13 indexed citations
17.
Colao, Annamaria, Filomena de Nigris, Roberta Modica, & Claudio Napoli. (2020). Clinical Epigenetics of Neuroendocrine Tumors: The Road Ahead. Frontiers in Endocrinology. 11. 604341–604341. 34 indexed citations
18.
Cimmino, Ilaria, Antongiulio Faggiano, Giuseppe Perruolo, et al.. (2020). Diagnosis of Flier’s syndrome in a patient with nondiabetic hypoglycemia: a case report and critical appraisal of the literature. Endocrine. 69(1). 73–78. 6 indexed citations
19.
Altieri, Barbara, Luigi Barrea, Roberta Modica, et al.. (2018). Nutrition and neuroendocrine tumors: An update of the literature. Reviews in Endocrine and Metabolic Disorders. 19(2). 159–167. 37 indexed citations
20.
Prete, Michela Del, Roberta Modica, Francesco Lassandro, et al.. (2017). Role of contrast-enhanced ultrasound to define prognosis and predict response to biotherapy in pancreatic neuroendocrine tumors. Journal of Endocrinological Investigation. 40(12). 1373–1380. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026